IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

QVT Financial LP

Q1 2014 Holdings

Filed 2014-05-14 | 82 holdings | $7.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Dyax CorpCOM26746E103$20.7K2,309,0000.3%
Altisource Portfolio Solns SREG SHSL0175J104$20.8K171,2540.3%
Wells Fargo & Co New(WFC)COM949746101$21.4K430,4560.3%
JPMorgan Chase & Co(JPM)COM46625H100$23.3K383,7700.3%
Anacor Pharmaceuticals IncCOM032420101$23.5K1,175,9030.3%
Intermune IncNOTE 2.500%12/145884XAF0$23.8K$9,000,0000.3%
Northstar Rlty FIN CorpCOM66704R100$24.4K1,511,6930.3%
Lululemon Athletica Inc(LULU)PutCOM550021109$25.3K480,7000.3%
Green DOT Corp(GDOT)CL A39304D102$25.7K1,315,8970.4%
Clovis Oncology Inc(CLVSEUR)COM189464100$27.0K389,7350.4%
Legg Mason Inc(LMEUR)COM524901105$27.8K565,8670.4%
Agenus Inc(AGENEUR)COM NEW00847G705$28.1K9,259,2600.4%
DHT Holdings Inc(DHT)SHS NEWY2065G121$29.0K3,921,8000.4%
Lumber Liquidators Hldgs Inc(LLFLQ)COM55003T107$30.0K320,1070.4%
SVB Finl Group(SIVBEUR)PutCOM78486Q101$30.5K236,5000.4%
BRF SA(P5Y)SPONSORED ADR10552T107$32.2K1,611,3480.4%
Arrowhead Resh CorpCOM NEW042797209$32.4K2,024,7820.4%
Achillion Pharmaceuticals in(ACHNEUR)COM00448Q201$35.6K10,816,9530.5%
Ocwen Finl CorpPutCOM NEW675746309$37.2K950,0000.5%
Capital One Finl Corp(COF)COM14040H105$37.3K483,8650.5%
Retrophin IncCOM761299106$47.9K2,287,5830.7%
SBA Communications CorpNOTE 4.000%10/078388JAM8$52.3K$17,500,0000.7%
Ebay Inc(EBAY)COM278642103$53.0K959,8000.7%
Halozyme Therapeutics Inc(HALO)COM40637H109$53.6K4,218,8000.7%
Wesco Intl IncDBCV 6.000% 9/195082PAH8$56.4K$19,000,0000.8%
YPF Sociedad Anonima(YPF)SPON ADR CL D984245100$57.9K1,858,2090.8%
E Trade Financial CorpNOTE 8/3269246AZ7$58.4K$26,214,0000.8%
Ocwen Finl CorpCOM NEW675746309$65.9K1,682,4920.9%
Tenet Healthcare Corp(THC)COM NEW88033G407$70.4K1,644,7141.0%
Lumber Liquidators Hldgs Inc(LLFLQ)PutCOM55003T107$90.2K961,8001.2%
Salesforce COM IncNOTE 0.750% 1/179466LAB0$140.0K$52,500,0001.9%
Biocryst Pharmaceuticals(BCRX)COM09058V103$5.6M525,73476.2%
PreviousPage 2 of 2